NICE recommends Lucentis (Novartis) for Diabetic Macular Oedema - 06-Oct-2012
NICE will now recommend Lucentis (ranibizumab) from Novartis for the treatment of Diabetic Macular Oedema. This is a change from previous draft guidance, which recommended against using the drug for this condition, The new decision is made after after Novartis agreed to drop the price of its drug.
In draft guidance, Lucentis is now recommended as an option for treating visual impairment caused by Diabetic Macular Oedema. A final decision is expected by February 2013. At present only laser photocoagulation is recommended for this condition.
Related News
NICE now recommends Iluvien (Alimera Sciences) for DME
Study shows Anti-VEGF treatments could cause harmful side-effects in the eye
NICE recommends Lucentis (Novartis) for Diabetic Macular Oedema
FDA approves Lucentis (Genentech) for treatment of Diabetic Macular Edema
NICE rejects Iluvien(Alimera Sciences)for DME treatment
FDA Advisory Committee recommends Lucentis (Genentech) for treatment of Diabetic Macular Edema
Positive results for Optina (Ampio) in patients with Diabetic Macular Oedema
Positive update from Phase II trial of Optina (Ampio Pharma) for Diabetic Macular Oedema
Related Eye Health and Disorders Information
Eye Health and Disorders Clinical Guidelines
Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension
NICEEye Health and Disorders Medical Journal Abstracts
Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout; A pilot randomised controlled trial
Arthritis & Rheumatism 16 May 2013Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout; A pilot randomised controlled trial
Arthritis & Rheumatism 16 May 2013Eye Health and Disorders Medical Apps
Clinical and experimental Opthalmology
Free
Eye Handbook
Free
Related Eye Health and Disorders Drugs
- RAPITIL
- AZOPT
- MINIMS DEXAMETHASONE SODIUM PHOSPHATE 0.1% W/V, EYE DROPOS SOLUTION
- OTRIVINE-ANTISTIN
- FUCITHALMIC
- DUOTRAV EYE DROPS
- VOTRIENT 200 MG FILM-COATED TABLETS
- NEOMYCIN (EYE)
- ALPHAGAN
- LUCENTIS 10 MG/ML SOLUTION FOR INJECTION
- CILOXAN 3MG/G EYE OINTMENT
- DORZOLAMIDE/TIMOLOL 20MG/ML + 5MG/ML EYE DROPS, SOLUTION
- OCUFEN
- LUBRI-TEARS
- HOMATROPINE
- CHLOROMYTOL 0.5% W/V EYE DROPS
- CILOXAN 0.3% W/V EYE DROPS, SOLUTION
- VIRGAN
- ARTELAC SDU
- DIAMOX SODIUM 500MG POWDER FOR SOLUTION FOR INJECTION
- MINIMS ARTIFICIAL TEARS
- MINIMS CYCLOPENTOLATE HYDROCHLORIDE
- ATROPINE (GENERIC-EYE)
- BETOPTIC
- VEXOL 1% EYE DROPS, SUSPENSION
- IOCARE
- OZURDEX
- VOLTAROL OPHTHA MULTIDOSE 0.1% EYE DROPS
- XALATAN
- GELTEARS
- ZOVIRAX EYE OINTMENT
- LACRI-LUBE
- MAXITROL OINTMENT
- TIMOLOL
- VISUDYNE 15 MG, POWDER FOR SOLUTION FOR INFUSION
- NEOSPORIN
- EMADINE 0.05% W/V, EYE DROPS, SOLUTION
- SOFRAMYCIN
- PROPINE
- FML
- TOBRADEX
- MINIMS ATROPINE SULPHATE
- BETAGAN
- MINIMS CHLORAMPHENICOL
- ALOMIDE 0.1% W/V
- CELLUVISC
- LUMIGAN EYE DROPS
- COMBIGAN SOLUTION
- OPTILAST
- HYPROMELLOSE EYE DROPS BP
- POLYFAX OINTMENT
- VOLTAROL OPHTHA (INFLAMMATION)
- DIAMOX TABLETS 250MG
- MOXIVIG 0.5%W/V EYE DROPS, SOLUTION
- PRED FORTE
- POLYTRIM
- LIQUIFILM TEARS
- CHLOROMYCETIN
- PILOCARPINE HYDROCHLORIDE
- OCULOTECT
- MYDRILATE
- BROCHLOR EYE DROPS
- ISOPTO PLAIN
- EYLEA 40MG/ML SOLUTION FOR INJECTION IN A VIAL
- TRUSOPT
- ILUBE
- ACULAR
- COSOPT PRESERVATIVE-FREE, SINGLE DOSE EYE DROPS
- VOTRIENT 200 MG AND 400 MG FILM COATED TABLETS
- ISOPTO ALKALINE
- TEOPTIC 1% - TEOPTIC 2%
- FLUORETS
- PHENYLEPHRINE EYE DROPS
- VISCOTEARS LIQUID GEL
- MYDRIACYL 1%
- IOPIDINE
- CHLORAMPHENICOL EYE DROPS & OINTMENT
- OPTICROM
- MACUGEN
- EXOCIN
- VOTRIENT 200 MG FILM-COATED TABLETS
- MAXIDEX
Advert for Healthcare Professionals only